NEDD8 Antibody,Biotin conjugated

Shipped with Ice Packs
In Stock

Description

Biotin-Conjugated NEDD8: Core Characteristics

Biotinylated NEDD8 (human recombinant) serves as a detection-optimized alternative to radioisotope-labeled versions. Key features include:

PropertySpecification
Conjugation TypeBiotinylated at multiple lysine residues (exact sites unmapped)
Activation PathwayCompatible with NEDD8 E1 enzyme and E2 conjugating enzyme UbcH12
Functional UtilityEnables substrate conjugation via NEDD8 E3 ligases
Purification PotentialFacilitates affinity purification via streptavidin/avidin matrices
Regulatory StatusRUO (Research Use Only)

Derived from recombinant human His-tagged NEDD8, this reagent supports in vitro studies of neddylation dynamics while avoiding radioactivity-associated hazards .

Complementary Antibody Tools for NEDD8 Detection

While not directly biotin-conjugated, the NEDD8 antibody (16777-1-AP) from Proteintech enables downstream detection and validation:

ParameterDetails
Host SpeciesRabbit IgG (polyclonal)
Tested ApplicationsWB (1:500–1:2000), IHC (1:20–1:200), IF, ELISA
Observed MW6–10 kDa (vs. calculated 9 kDa)
ReactivityConfirmed in human, mouse, rat, monkey tissues
Key Publications7 peer-reviewed studies, including cancer and neurodegenerative disease models

This antibody detects endogenous NEDD8 across species and experimental conditions, with validated performance in Western blot (WB) of brain/heart tissues and immunohistochemistry (IHC) of colon cancer samples .

Mechanistic Insights

  • Neddylation Cascade: Biotinylated NEDD8 participates in the enzymatic cascade involving E1 (APPBP1-Uba3), E2 (Ubc12), and E3 ligases, enabling substrate conjugation .

  • Cell Cycle Regulation: Studies in Uba3−/− mice demonstrate NEDD8’s essential role in S-phase entry and cyclin E/p57<sup>Kip2</sup> regulation, linking neddylation to cell cycle control .

  • Disease Relevance: Accumulation of β-catenin in NEDD8-deficient systems highlights its role in Wnt signaling and proteasomal degradation pathways .

Technical Advantages

  • Detection Flexibility: Biotinylation allows chemiluminescent or fluorescent detection without radioactivity .

  • Protocol Compatibility: Validated protocols include antigen retrieval with TE buffer (pH 9.0) for IHC and standard WB conditions .

Strategic Workflow Integration

A typical experimental pipeline combines these tools:

  1. Conjugation: Biotinylated NEDD8 + E1/E2/E3 enzymes → substrate modification .

  2. Affinity Capture: Streptavidin pulldown of neddylated substrates .

  3. Validation: Antibody-based detection (WB/IHC) confirms target identity and modification status .

Limitations and Considerations

  • Epitope Accessibility: NEDD8’s small size (81 aa) may challenge antibody binding in certain conformations .

  • Biotinylation Heterogeneity: Multiple biotinylation sites could influence enzyme kinetics or steric effects .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship your orders within 1-3 business days after receiving them. The delivery time may vary depending on the purchasing method or location. Please contact your local distributor for specific delivery timeframes.
Synonyms
FLJ43224 antibody; MGC104393 antibody; MGC125896 antibody; MGC125897 antibody; NED8 antibody; NEDD 8 antibody; NEDD-8 antibody; Nedd8 antibody; NEDD8_HUMAN antibody; Neddylin antibody; Neural precursor cell expressed developmentally down regulated 8 antibody; Neural precursor cell expressed developmentally down regulated gene 8 antibody; Neural precursor cell expressed developmentally down-regulated protein 8 antibody; Rub1 antibody; Ubiquitin like protein Nedd 8 antibody; Ubiquitin like protein Nedd8 antibody; Ubiquitin-like protein Nedd8 antibody
Target Names
NEDD8
Uniprot No.

Target Background

Function
NEDD8 (Neural precursor cell-expressed, developmentally downregulated 8) is a ubiquitin-like protein that plays a significant role in cell cycle control and embryogenesis. It achieves this by conjugating to a limited number of cellular proteins, including cullins and p53/TP53. NEDD8 attachment to cullins is crucial for recruiting E2 to the cullin-RING-based E3 ubiquitin-protein ligase complex. This process facilitates polyubiquitination and proteasomal degradation of cyclins and other regulatory proteins. On the other hand, NEDD8 conjugation to p53/TP53 inhibits its transcriptional activity. The covalent attachment of NEDD8 to its substrates requires prior activation by the E1 complex UBE1C-APPBP1 and subsequent linkage to the E2 enzyme UBE2M.
Gene References Into Functions
  1. Nedd8 binding to Smurf plays critical roles in the regulation of cell migration and the BMP and TGFbeta signaling pathways. PMID: 28169289
  2. NEDD8-mediated neddylation promotes stress granule assembly. PMID: 27381497
  3. NEDD8 appears to inhibit Src-mediated phosphorylation of caveolin-1 by modifying the structure of caveolin-1 protein, thereby hindering the migration of cancer cells. While neddylation is currently considered a promising target for cancer therapy, our findings suggest that inhibiting neddylation could potentially facilitate cancer invasion or metastasis in certain types of cancers. PMID: 29301501
  4. The cellular effects of NEDD8 inhibition can be manipulated based on the p53 status. PMID: 27901050
  5. Our research indicates that high expression of neddylation components, NEDD8 and NAE1, is associated with poor survival in Pancreatic ductal adenocarcinoma patients. Blocking neddylation using MLN4924 significantly sensitizes pancreatic cancer cells to gemcitabine, reduces clonogenic survival, diminishes invasion capacity, and increases apoptosis and senescence. PMID: 28535453
  6. Downregulation of NEDD8 enhanced the susceptibility of nasopharyngeal carcinoma cells to cisplatin and radiation. PMID: 28569775
  7. Furthermore, the authors characterized SENP8/DEN1 as the protease that counteracts Ubc12 auto-neddylation and observed aberrant neddylation of Ubc12 and other NEDD8 conjugation pathway components in SENP8-deficient cells. PMID: 28475037
  8. MKK7 undergoes neddylation in human breast cancer cells. PMID: 26364603
  9. Complete blocking of CRLs at a higher inhibitor dose induced cytotoxicity that was amplified by knockdown of CRL regulator Cand1. PMID: 27906189
  10. In conclusion, our research reveals that E3 ligase HDM2 promotes NEDD8 NEDDylation of HBx to enhance HBx stability and chromatin localization. This, in turn, favors HBx-dependent transcriptional regulation, cell proliferation, and hepatitis B virus-driven tumor growth. PMID: 28592528
  11. CUL5 neddylation may allosterically tune polyubiquitin chain length and topology. PMID: 28082425
  12. This study identifies MyD88 as a novel substrate of NEDD8 and demonstrates that MyD88 NEDDylation antagonizes its ubiquitination. PMID: 27864145
  13. This study provides new insights into the CFTR biosynthetic pathway. It suggests that SYVN1 and FBXO2 represent two distinct multiprotein complexes that may degrade DeltaF508-CFTR in airway epithelia and identifies a new role for NEDD8 in regulating DeltaF508-CFTR ubiquitination. PMID: 27756846
  14. Neddylation of Smurf1 activates its ubiquitin ligase activity, and Smurf2 exerts Nedd8 ligase activity. This study provided new clues to Smurf2 activation regulation. PMID: 27086113
  15. Nedd8(Q40E) cannot induce the same structural effect on Cul1-Rbx1 as wild-type Nedd8. PMID: 26632597
  16. These findings add novel evidence demonstrating, for what we believe is the first time, that NEDD8-mediated neddylation is required for normal human endometrial functions. PMID: 26003431
  17. In endothelial dysfunction, HDAC2 levels were reciprocally regulated by ectopic expression of NEDD8 and the de-NEDDylating enzyme SENP8. PMID: 25655932
  18. We report that MLN4924 (NEDD8 enzyme inhibitor) specifically inhibited protein neddylation, inactivated cullin-RING E3 ligase (CRL), the best-known neddylation substrate, and induced the accumulation of CRL substrates in lymphoma cells. PMID: 25782162
  19. E1 (NAE1 and UBA3) and E2 (UBC12) enzymes, as well as global NEDD8 conjugation, were upregulated in over 2/3 of human intrahepatic cholangiocarcinoma. PMID: 25229838
  20. This work sheds new light on the roles of NEDD8 lysines on neddylation cascades and provides a dominant negative mutant for the study of neddylation and its biological functions. PMID: 25918018
  21. A role of Nedd8 in regulating caspase-1 activation following inflammasome activation has been observed. PMID: 25452302
  22. NEDD8 negatively regulates the DNA damage repair process through suppression of the ubiquitylation of H2A and gammaH2AX, which further blocks the recruitment of the damage response protein BRCA1. PMID: 24634510
  23. SCCRO3 functions as a tumor suppressor by antagonizing the neddylation activity of SCCRO. PMID: 25349211
  24. This study reports the structure of a trapped RING E3-E2 approximately UBL-target intermediate representing RBX1-UBC12 approximately NEDD8-CUL1-DCN1. This reveals the mechanism of NEDD8 ligation and how a particular UBL and acceptor lysine are matched by a multifunctional RING E3. PMID: 24949976
  25. Protein neddylation with NEDD8 protein plays a significant role in HIV-1 and HIV-2 infection. PMID: 24245672
  26. Importantly, RPS14 was specifically modified with NEDD8, and hCINAP inhibited RPS14 NEDDylation by recruiting NEDD8-specific protease 1. PMID: 23246961
  27. Our results suggest that NEDD8 may play a significant role in controlling the proliferation and differentiation of human placenta throughout pregnancy. PMID: 23812220
  28. In coordination with the P97-UFD1-NPL4 complex (P97(UFD1/NPL4)), NUB1L promotes the transfer of NEDD8 to the proteasome for degradation. PMID: 24019527
  29. These results indicate that NAE1/APP-BP1 and NEDDylation are involved in modulating p53 activity and regulating its role in the response of cells to ionizing radiation. PMID: 22895816
  30. Data indicate that overexpression of SENP8, a NEDD8-specific cysteine protease, resulted in deNEDDylation of E2F1 and promoted its transactivation activity at the p73 gene. PMID: 23001041
  31. These studies demonstrate that disrupting host NEDD8 cascades presents a novel antiretroviral therapeutic approach, enhancing the ability of the immune system to combat HIV. PMID: 23300442
  32. These findings suggest that once Rub1/Nedd8 is channeled into ubiquitin pathways, it is recognized essentially like ubiquitin. PMID: 23105008
  33. NEDD8 modifies transcription factor E2F-1. PMID: 22836579
  34. Histone H4 was polyneddylated in response to DNA damage, and NEDD8 was conjugated to the N-terminal lysine residues of H4. PMID: 23394999
  35. A new regulatory mechanism of RCAN1 function has been identified. PMID: 23118980
  36. c-Cbl conjugates neural precursor cell-expressed, developmentally downregulated 8 (NEDD8), a ubiquitin-like protein, to TbetaRII at Lys556 and Lys567. PMID: 23290524
  37. Neddylation is achieved via a multienzyme process wherein SENP8 enables cleavage of the Nedd8 precursor and promotes Nedd8 conjugation to the Cullin-RING ligases. PMID: 23209320
  38. This research presents a view of how a bacterial deamidase effector, cycle-inhibiting factor homolog in Burkholderia pseudomallei, recognizes its host targets, ubiquitin (Ub) and Ub-like NEDD8, and catalyzes site-specific deamidation. PMID: 23175788
  39. Deconjugation of Nedd8 from Cul1 is directly regulated by Skp1-F-box and substrate, and the COP9 signalosome inhibits deneddylated SCF by a noncatalytic mechanism. PMID: 22767593
  40. In this study, the proportions of intranuclear inclusion positive for NEDD8, NUB1, and SUMO-1 were significantly lower in glial cells than in neurons. PMID: 22612509
  41. We report the crystal structures of two Cif/NEDD8 complexes, revealing a conserved molecular interface that defines enzyme/substrate recognition. PMID: 22691497
  42. Decrease in free ubiquitin levels under stress allows NEDD8 to be conjugated through Ube1. PMID: 22370482
  43. The studies provide insights on how nucleolar stress through L11 and NEDD8 can activate the transcriptional activity of p53. PMID: 22081073
  44. High NEDD8 is associated with melanoma. PMID: 22502714
  45. XIAP does not function as a NEDD8-E3 ligase for caspase-7 in vivo. PMID: 22584050
  46. These results uncover an unexpected and conserved role for NEDD8 in linking cullin-RING ubiquitin ligases ubiquitin ligase function to the p97 pathway. PMID: 22466964
  47. The Mdm2/NEDD8/HuR regulatory framework is essential for the malignant transformation of tumor cells. PMID: 22095636
  48. E1-E2 interactions in ubiquitin and Nedd8 ligation pathways. PMID: 22069333
  49. In cells, NEDD8 overexpression leads to this type of NEDDylation by increasing the concentration of NEDD8, whereas proteasome inhibition has the same effect by depleting free ubiquitin. PMID: 22004789
  50. These findings suggest that TRIM40 inhibits NF-kappaB activity via neddylation of inhibitor of nuclear factor kappaB kinase subunit gamma and that TRIM40 prevents inflammation-associated carcinogenesis in the gastrointestinal tract. PMID: 21474709

Show More

Hide All

Database Links

HGNC: 7732

OMIM: 603171

KEGG: hsa:4738

STRING: 9606.ENSP00000250495

UniGene: Hs.531064

Protein Families
Ubiquitin family
Subcellular Location
Nucleus.
Tissue Specificity
Highly expressed in heart, skeletal muscle, spleen, thymus, prostate, testis, ovary, colon and leukocytes.

Q&A

What is NEDD8 and what role does it play in cellular processes?

NEDD8 (Neural precursor cell expressed developmentally down-regulated protein 8) is a ubiquitin-like modifier that shares approximately 80% homology with ubiquitin and plays a crucial role in regulating protein degradation pathways. NEDD8 functions primarily through its conjugation to a limited number of cellular proteins, such as cullins and p53/TP53, thereby regulating cell cycle control and embryogenesis. NEDD8 is predominantly localized in the nucleus and is highly expressed in adult heart, skeletal muscle, spleen, thymus, prostate, testis, ovary, colon, and leukocytes, indicating its importance in maintaining cellular homeostasis across multiple tissues . Understanding NEDD8's regulatory functions provides critical insight into fundamental cellular processes including protein degradation, cell cycle progression, and signal transduction pathways.

What are the structural characteristics of biotinylated NEDD8 that make it useful for research?

Biotinylated NEDD8 contains approximately 9 lysine residues that serve as potential biotinylation sites, creating a protein with a molecular weight of approximately 11 kDa (based on Bt3-NEDD8 as the predominant form). The biotin conjugation provides several key advantages for research applications: it creates a readily detectable alternative to radio-iodinated NEDD8, enables visualization through various streptavidin-conjugated detection systems, and facilitates affinity purification of conjugated substrates or thiol ester-linked enzymes using avidin/streptavidin matrices . The strategic placement of biotin molecules on NEDD8 preserves the protein's ability to be activated by NEDD8 E1 and function as a competent substrate for the NEDD8 E2 conjugating enzyme UbcH12, maintaining its biological functionality while adding experimental versatility.

How does the NEDDylation pathway differ from ubiquitination, and why are specialized tools needed?

While NEDDylation shares similarities with ubiquitination in utilizing an E1-E2-E3 enzyme cascade, the pathways differ in several critical aspects. NEDDylation employs specific enzymes including the E1 activating enzyme UBA2, E2 conjugating enzyme Ubc12, and specialized E3 ligases that recognize unique structural features of NEDD8 . Unlike ubiquitination which typically targets proteins for degradation, NEDDylation primarily functions as a regulatory modification that alters protein activity or interactions. The specificity of NEDDylation for a more limited set of substrates (particularly cullins) necessitates specialized tools like biotinylated NEDD8 that can distinguish between these closely related pathways. These differences in substrate range, enzymatic machinery, and biological outcomes make biotin-conjugated NEDD8 antibodies essential for specifically tracking and analyzing NEDDylation events without cross-reactivity with the more abundant ubiquitination modifications.

What are the optimal applications for biotin-conjugated NEDD8 antibodies versus recombinant biotinylated NEDD8 protein?

Biotin-conjugated NEDD8 antibodies and recombinant biotinylated NEDD8 proteins serve complementary but distinct research purposes. Biotin-conjugated antibodies excel in detection applications including Western blotting (1:10,000 dilution), immunoprecipitation (1:200 dilution), and ELISA (1:500 dilution), allowing researchers to visualize endogenous NEDDylation patterns in cellular systems . In contrast, recombinant biotinylated NEDD8 protein is particularly valuable for in vitro NEDDylation assays, serving as a substrate to reconstruct the NEDDylation cascade, and for affinity purification of NEDDylation enzymes or substrates . When designing experiments, researchers should select biotinylated antibodies when the goal is to detect or quantify NEDDylated proteins in biological samples, while choosing recombinant biotinylated NEDD8 when reconstituting NEDDylation reactions or identifying novel NEDDylation substrates through affinity-based approaches.

How can I design a comprehensive NEDDylation assay using biotinylated NEDD8?

A comprehensive NEDDylation assay using biotinylated NEDD8 should include the following components and considerations:

  • Reaction components:

    • Purified biotinylated NEDD8 (reconstituted from lyophilized form with sterile distilled water)

    • NEDD8 E1 activating enzyme (UBA2)

    • NEDD8 E2 conjugating enzyme (UbcH12)

    • Appropriate NEDD8 E3 ligase (depending on substrate)

    • Potential substrate protein

    • ATP regeneration system (ATP, creatine phosphate, creatine kinase)

    • Buffer containing Mg²⁺ and DTT

  • Detection methods:

    • Streptavidin-HRP for Western blotting

    • Streptavidin-coupled beads for pull-down assays

    • Anti-NEDD8 antibodies as confirmatory detection

This experimental design allows for monitoring NEDDylation through multiple approaches, including visualizing substrate modification by electrophoretic mobility shift, detecting biotinylated NEDD8 conjugates via streptavidin, and confirming specificity through anti-NEDD8 immunodetection . The assay can be extended to include inhibitors of NEDDylation (such as MLN4924) as controls to validate the specificity of observed modifications.

What controls should be included when using biotin-conjugated NEDD8 antibodies in immunofluorescence studies?

When performing immunofluorescence studies with biotin-conjugated NEDD8 antibodies, the following essential controls should be included:

  • Negative controls:

    • Secondary antibody-only control (omitting primary antibody)

    • Isotype control antibody (matched IgG class)

    • Cells treated with NEDD8 E1 inhibitor (MLN4924)

    • Peptide competition assay using the immunizing peptide (regions 50-81 of human NEDD8)

  • Positive controls:

    • Cells overexpressing NEDD8 or known NEDDylated proteins

    • Tissues known to express high levels of NEDD8 (heart, skeletal muscle)

    • Parallel validation with a different anti-NEDD8 antibody

  • Specificity verification:

    • NEDD8 knockdown/knockout cells

    • Co-staining with antibodies against known NEDDylated cullins

These controls help distinguish specific NEDD8 staining from background signal, validate subcellular localization patterns, and confirm the antibody's specificity for NEDDylated proteins versus free NEDD8 or cross-reactivity with ubiquitin, which shares significant homology with NEDD8 .

How can I distinguish between ubiquitination and NEDDylation when analyzing protein modifications?

Distinguishing between ubiquitination and NEDDylation presents a significant challenge due to the high sequence homology (80%) between NEDD8 and ubiquitin . Implement these methodological approaches to achieve reliable differentiation:

  • Antibody specificity validation:

    • Use antibodies raised against unique regions of NEDD8 (such as peptides from amino acids 50-81)

    • Perform peptide competition assays to confirm specificity

    • Validate with NEDD8 knockout/knockdown samples

  • Enzymatic manipulation:

    • Utilize specific inhibitors of NEDDylation (MLN4924) versus ubiquitination (proteasome inhibitors)

    • Express dominant-negative versions of NEDD8-specific enzymes (UbcH12)

    • Use deNEDDylating enzymes (SENP8/NEDP1) that specifically cleave NEDD8 conjugates

  • Mass spectrometry-based identification:

    • Analyze the branch point peptides to identify NEDD8-specific versus ubiquitin-specific conjugation sites

    • Examine tryptic digestion patterns that yield characteristic peptides for each modifier

These approaches, used in combination, provide multiple lines of evidence to distinguish between these related but functionally distinct protein modifications, enabling more accurate interpretation of experimental results.

What factors affect the efficiency of biotinylated NEDD8 conjugation in in vitro assays?

Several critical factors influence biotinylated NEDD8 conjugation efficiency in vitro:

  • Enzyme ratios and concentrations:

    • The molar ratio between E1:E2:E3 enzymes significantly impacts conjugation efficiency

    • Optimal E1 concentration typically ranges from 50-100 nM

    • E2 (UbcH12) concentration is typically 0.5-1 μM

    • E3 ligase concentration varies depending on the specific ligase but often ranges from 100-500 nM

  • Reaction conditions:

    • Temperature (30°C typically optimal, not 37°C)

    • pH (7.5-8.0 typically optimal)

    • ATP concentration (1-5 mM) and regeneration system

    • Divalent cation concentration (especially Mg²⁺, 5-10 mM)

    • Reducing agent concentration (DTT, 0.5-1 mM)

  • Technical considerations:

    • Biotinylation degree (excessive biotinylation can impair NEDD8 function)

    • Proper protein reconstitution and storage to maintain activity

    • Avoiding freeze/thaw cycles that may reduce enzyme activity

Optimizing these parameters through systematic testing is essential for establishing robust NEDDylation assays, as suboptimal conditions can lead to false negatives or significantly reduced conjugation efficiency.

How can I minimize non-specific binding when using biotin-conjugated NEDD8 antibodies?

Non-specific binding presents a common challenge when working with biotin-conjugated antibodies. Implement these strategies to improve specificity:

  • Blocking optimization:

    • Use bovine serum albumin (BSA, 1-5%) or casein-based blockers (not milk when using biotin-streptavidin systems)

    • Include 0.1-0.3% Triton X-100 or 0.05-0.1% Tween-20 in blocking solutions

    • Consider adding avidin/streptavidin blocking steps to neutralize endogenous biotin

  • Antibody preparation:

    • Pre-adsorb antibodies against tissues from NEDD8 knockout models

    • Optimize antibody dilution through titration (starting with 1:10,000 for Western blot)

    • Centrifuge antibody solution before use to remove aggregates

  • Sample preparation:

    • Include deubiquitinase inhibitors but not inhibitors that affect NEDD8 pathway

    • Fix samples appropriately (4% paraformaldehyde for immunofluorescence)

    • Perform stringent washes with buffers containing 0.1-0.5% Tween-20 or 0.1% Triton X-100

These approaches significantly reduce background while maintaining specific signal, yielding cleaner results in applications including Western blotting, immunohistochemistry, and immunoprecipitation experiments.

How can biotinylated NEDD8 be used to identify novel NEDDylation substrates?

Identifying novel NEDDylation substrates requires strategic experimental approaches leveraging the unique properties of biotinylated NEDD8:

  • Affinity purification coupled with mass spectrometry:

    • Reconstitute in vitro NEDDylation reactions using biotinylated NEDD8, E1, E2, and cellular extracts

    • Capture biotinylated NEDD8 conjugates using streptavidin matrices

    • Perform on-bead tryptic digestion followed by LC-MS/MS analysis

    • Analyze data using specialized algorithms to identify branch-point peptides

  • Cellular expression systems:

    • Express biotinylated NEDD8 in cells using a BirA-fusion system

    • Incorporate proteasome inhibitors and NEDD8-activating enzyme inhibitors as controls

    • Perform tandem purification using streptavidin followed by anti-NEDD8 immunoprecipitation

    • Validate candidates through targeted approaches including site-directed mutagenesis

  • Proximity-based labeling:

    • Create fusion proteins between NEDD8 E2/E3 enzymes and promiscuous biotin ligases (BioID, TurboID)

    • Identify proteins in proximity to NEDDylation machinery

    • Cross-validate with direct NEDDylation assays

This multifaceted approach enables comprehensive mapping of the NEDDylation substrate landscape while minimizing false positives through stringent validation steps .

How do I analyze NEDDylation dynamics in response to cellular stress using biotinylated tools?

Analyzing NEDDylation dynamics during cellular stress requires time-resolved approaches:

  • Pulse-chase experimental design:

    • Pulse cells with biotin-labeled precursors that can be incorporated into NEDD8

    • Apply stress conditions (oxidative stress, heat shock, hypoxia, DNA damage)

    • Chase at defined timepoints and analyze NEDDylation patterns

    • Quantify the ratio of conjugated versus free NEDD8

  • Live-cell imaging approaches:

    • Express fluorescently tagged NEDD8 alongside biotin-based proximity sensors

    • Monitor redistribution and enzyme association in real-time during stress

    • Perform fluorescence recovery after photobleaching (FRAP) to assess dynamic turnover

  • Quantitative proteomics:

    • Use SILAC or TMT labeling combined with biotin-based NEDD8 purification

    • Compare stress versus normal conditions across multiple timepoints

    • Develop computational models of NEDDylation/deNEDDylation kinetics

This comprehensive strategy reveals both global and substrate-specific changes in NEDDylation patterns during stress responses, providing insight into regulatory mechanisms and potential therapeutic interventions targeting the NEDD8 pathway .

What approaches can be used to study the crosstalk between NEDDylation and other post-translational modifications?

Investigating the crosstalk between NEDDylation and other post-translational modifications (PTMs) requires sophisticated methodological approaches:

  • Sequential enrichment strategies:

    • First enrichment: Capture biotinylated NEDD8 conjugates using streptavidin

    • Second enrichment: Use antibodies against other PTMs (phosphorylation, acetylation, SUMOylation)

    • Analysis: Identify multiply-modified proteins and modification site relationships

  • Engineered protein systems:

    • Create proteins with mutations at known PTM sites

    • Assess how these mutations affect NEDDylation efficiency in vitro

    • Examine competition or cooperation between modifications using reconstituted systems

  • Enzyme manipulation experiments:

    • Inhibit or deplete writers/erasers of other PTMs

    • Monitor effects on global NEDDylation patterns using biotin-NEDD8 antibodies

    • Perform reciprocal experiments by manipulating NEDD8 pathway components

  • Structural analysis:

    • Study how pre-existing PTMs affect recognition by NEDD8 E3 ligases

    • Examine structural changes in substrates following sequential modification

These integrated approaches reveal the complex regulatory networks governing protein function through combinatorial post-translational modifications, providing deeper insight into cellular signaling pathways and regulatory mechanisms .

What statistical approaches should be used when quantifying NEDDylation levels across experimental conditions?

Robust statistical analysis of NEDDylation data requires:

  • Normalization strategies:

    • Normalize NEDDylated protein signal to total protein abundance

    • Use multiple housekeeping controls appropriate for the experimental condition

    • Consider internal standardization with spike-in controls

  • Statistical tests based on experimental design:

    • For simple comparisons: paired t-tests or Wilcoxon signed-rank tests

    • For multiple conditions: ANOVA with appropriate post-hoc tests (Tukey, Dunnett)

    • For complex designs: mixed-effects models accounting for biological replicates

  • Data visualization and reporting:

    • Present raw blot images alongside quantification

    • Show individual data points rather than only means and error bars

    • Report effect sizes along with p-values

  • Specialized considerations for NEDDylation:

    • Account for the distinct bands representing mono-NEDDylation versus poly-NEDDylation

    • Consider the ratio of free versus conjugated NEDD8 as a metric

    • Integrate data across multiple detection methods (antibody-based and biotin-based)

These approaches ensure rigorous interpretation of NEDDylation data while accounting for biological variability and technical limitations of detection methods .

How can I distinguish between specific NEDDylation signals and artifacts when using biotinylated tools?

Distinguishing authentic NEDDylation signals from artifacts requires systematic validation:

  • Control experiments:

    • Compare results with and without ATP in in vitro systems

    • Use NEDD8-activating enzyme inhibitors (MLN4924) as negative controls

    • Include NEDD8 processing enzyme mutants that prevent conjugation

  • Confirmation across multiple detection methods:

    • Verify results using both anti-NEDD8 antibodies and streptavidin detection

    • Perform reciprocal immunoprecipitation experiments

    • Confirm with mass spectrometry identification of the NEDD8 remnant on substrate

  • Artifact identification:

    • Check for endogenous biotinylated proteins (carboxylases are common contaminants)

    • Test for non-enzymatic binding of NEDD8 to proteins under experimental conditions

    • Validate with mutation of the substrate's target lysine residues

  • Biological validation:

    • Confirm physiological relevance through genetic manipulation of the NEDDylation pathway

    • Assess conservation of the modification across species or cell types

    • Correlate modification with functional outcomes

What are the current limitations in NEDDylation research using biotinylated tools, and how might they be addressed?

Current limitations in NEDDylation research using biotinylated tools include:

  • Technical challenges:

    • Biotinylation sites on NEDD8 are not precisely mapped, potentially affecting function

    • Possible interference with NEDDylation machinery or substrate recognition

    • Cross-reactivity with the ubiquitin pathway due to high sequence homology

    Potential solutions: Develop site-specifically biotinylated NEDD8 variants; create bifunctional probes with minimal structural impact; employ genetic code expansion for precise modification

  • Detection sensitivity limits:

    • Low abundance of many NEDDylated proteins

    • Rapid turnover of some NEDDylation events

    • Competition with endogenous NEDD8

    Potential solutions: Develop more sensitive detection methods combining biotin with additional tags; employ advanced mass spectrometry approaches; develop real-time sensors for NEDDylation dynamics

  • Data interpretation challenges:

    • Distinguishing direct NEDDylation from indirect effects on cullin-RING ligases

    • Understanding the functional impact of NEDDylation versus ubiquitination

    • Separating physiological versus stress-induced NEDDylation

    Potential solutions: Develop computational models integrating multiple data types; create targeted approaches for site-specific NEDDylation analysis; establish improved cellular systems with controllable NEDDylation machinery

Addressing these limitations through technological innovation and integrated experimental approaches will advance our understanding of NEDDylation's role in cellular physiology and disease pathogenesis .

What are the optimal storage conditions for maintaining the activity of biotin-conjugated NEDD8 antibodies and proteins?

Optimal storage conditions for biotin-conjugated NEDD8 reagents include:

  • Temperature considerations:

    • Store lyophilized biotinylated NEDD8 at -20°C for long-term storage

    • Store reconstituted protein in small aliquots at -80°C to minimize freeze-thaw cycles

    • Store biotin-conjugated antibodies at -20°C in antibody stabilization buffer

  • Buffer optimization:

    • Reconstitute lyophilized proteins in sterile distilled water or recommended buffer

    • For antibodies, maintain in buffers containing 50% glycerol to prevent freeze-thaw damage

    • Consider adding protein stabilizers (BSA, glycerol) for diluted antibodies

  • Handling practices:

    • Avoid repeated freeze-thaw cycles for all reagents

    • Centrifuge briefly before opening vials

    • Use sterile technique when handling reconstituted proteins

    • Store working dilutions at 4°C for no more than 1 week

  • Quality control measures:

    • Periodically verify activity using positive control reactions

    • Monitor for signs of aggregation or precipitation

    • Test biotinylation status using streptavidin-based detection methods

Adherence to these storage and handling recommendations ensures maximum retention of activity and extends the useful lifespan of these valuable research reagents .

How can I monitor the stability and activity of biotinylated NEDD8 over time?

Monitoring the stability and activity of biotinylated NEDD8 preparations over time is essential for experimental reproducibility:

  • Activity assays:

    • Perform periodic in vitro NEDDylation reactions using a well-characterized substrate

    • Compare conjugation efficiency to a reference standard or initial batch

    • Monitor E1 enzyme charging via non-reducing gel electrophoresis

  • Structural integrity assessment:

    • Use mass spectrometry to monitor for degradation products

    • Perform size-exclusion chromatography to detect aggregation

    • Verify biotinylation status using streptavidin binding assays

  • Stability indicators:

    • Create a stability monitoring schedule with defined checkpoints

    • Establish acceptance criteria for minimum activity

    • Document batch-to-batch variation to identify stability trends

  • Enhancing stability:

    • Add stabilizing agents (trehalose, glycerol) for long-term storage

    • Consider alternative formulations for improved stability

    • Investigate lyophilization conditions that maximize activity retention

Implementing these monitoring approaches enables researchers to maintain confidence in their experimental systems and identify potential stability issues before they impact experimental outcomes .

Storage ParameterBiotinylated NEDD8 ProteinBiotin-conjugated NEDD8 Antibody
Storage Temperature-20°C (lyophilized), -80°C (reconstituted)-20°C
Buffer CompositionPBS (lyophilized)Antibody stabilization buffer (0.5-1.5 μg/μl)
Stability Period≥12 months when stored properly≥12 months when stored properly
Recommended Aliquoting5-10 μl aliquots10-20 μl aliquots
Freeze/Thaw StabilityAvoid multiple cyclesLimited to 3-5 cycles
Working Solution Storage4°C for ≤1 week4°C for ≤2 weeks

How might biotinylated NEDD8 tools contribute to therapeutic development targeting the NEDDylation pathway?

Biotinylated NEDD8 tools offer significant potential for therapeutic development through multiple avenues:

  • High-throughput screening applications:

    • Development of in vitro NEDDylation assays using biotinylated NEDD8 for screening small molecule inhibitors

    • Establishment of cellular reporter systems incorporating biotinylated NEDD8 to monitor pathway modulation

    • Creation of competitive binding assays to identify molecules disrupting specific NEDD8-substrate interactions

  • Target validation approaches:

    • Identification of disease-specific NEDDylation substrates using biotinylated NEDD8 pulldown from patient samples

    • Characterization of aberrant NEDDylation patterns in cancer and neurodegenerative diseases

    • Validation of the therapeutic relevance of specific NEDDylation events through targeted modulation

  • Biomarker development:

    • Utilization of biotin-conjugated NEDD8 antibodies for developing diagnostic assays

    • Correlation of NEDDylation patterns with disease progression or treatment response

    • Identification of patient subgroups likely to respond to NEDD8 pathway inhibitors

These applications build on existing knowledge that NEDD8 pathway inhibitors show promise in treating various cancers, and biotinylated tools enable more precise targeting of specific branches of the NEDDylation pathway, potentially reducing off-target effects while maintaining therapeutic efficacy .

What are the emerging techniques for studying site-specific NEDDylation using biotinylated approaches?

Emerging techniques for studying site-specific NEDDylation combine biotinylation with advanced methodologies:

  • Proximity-based approaches:

    • BioID or TurboID fusion with NEDD8 pathway components to identify spatial organization

    • Split-biotin ligase complementation to detect transient NEDDylation enzyme-substrate interactions

    • Targeted biotinylation of specific lysine residues using engineered E2/E3 enzymes

  • Advanced mass spectrometry techniques:

    • Development of specialized enrichment strategies for NEDDylated peptides

    • Application of middle-down proteomics to preserve modification patterns

    • Ion mobility mass spectrometry to distinguish NEDD8 from ubiquitin modifications

  • Genetic code expansion technologies:

    • Site-specific incorporation of biotinylated lysine analogs

    • Creation of orthogonal NEDDylation systems for studying specific substrates

    • Development of photo-crosslinking approaches to capture transient NEDDylation machinery interactions

  • Single-molecule techniques:

    • FRET-based sensors to monitor NEDDylation in real-time

    • Super-resolution microscopy of biotinylated NEDD8 to visualize subcellular NEDDylation events

    • Single-molecule tracking to determine NEDDylation/deNEDDylation kinetics

These emerging approaches promise to provide unprecedented insights into the specificity, dynamics, and regulatory mechanisms of NEDDylation with potential applications in both basic research and therapeutic development .

How can multi-omics approaches incorporating biotinylated NEDD8 tools advance our understanding of NEDDylation biology?

Multi-omics approaches incorporating biotinylated NEDD8 tools enable comprehensive systems-level analysis:

  • Integrated proteomics and transcriptomics:

    • Correlation of NEDDylated substrates (identified via biotin pulldown) with transcript expression

    • Analysis of NEDDylation effects on protein stability and turnover rates

    • Identification of feedback mechanisms between NEDDylation and gene expression

  • Structural proteomics integration:

    • Hydrogen-deuterium exchange mass spectrometry to identify structural changes upon NEDDylation

    • Crosslinking mass spectrometry to map NEDDylation machinery interactions

    • Cryo-EM analysis of NEDDylated protein complexes purified via biotin-based approaches

  • Metabolomics connections:

    • Investigation of NEDDylation's role in metabolic enzyme regulation

    • Analysis of how cellular metabolic state influences NEDDylation dynamics

    • Examination of connections between energy status and NEDDylation pathway activity

  • Network modeling approaches:

    • Development of predictive models for NEDDylation substrate recognition

    • Integration of NEDDylation data with other PTM datasets

    • Simulation of NEDDylation dynamics under various cellular conditions

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.